Contact
Please use this form to send email to PR contact of this press release:
Breakthrough Testing with Nvidia AI Chips, Cyclomics and GEDICube; Early Cancer Detection: Renovaro: NASDAQ: RENB
TO:
The Hon. Mark Dybul, MD, CEO
Renovaro Biosciences Inc
+1 732-780-5036